Capital International Investors Reduces Stock Position in Elevance Health, Inc. $ELV

Capital International Investors lessened its stake in shares of Elevance Health, Inc. (NYSE:ELV) by 46.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,587,443 shares of the company’s stock after selling 1,367,274 shares during the quarter. Capital International Investors’ holdings in Elevance Health were worth $556,477,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Rossby Financial LCC grew its holdings in Elevance Health by 110.0% in the 3rd quarter. Rossby Financial LCC now owns 84 shares of the company’s stock valued at $28,000 after buying an additional 44 shares during the period. ORG Partners LLC grew its holdings in Elevance Health by 120.4% in the 4th quarter. ORG Partners LLC now owns 108 shares of the company’s stock valued at $38,000 after buying an additional 59 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new stake in Elevance Health in the 4th quarter valued at about $38,000. Dorato Capital Management purchased a new stake in Elevance Health in the 4th quarter valued at about $41,000. Finally, Flagship Harbor Advisors LLC purchased a new stake in Elevance Health in the 4th quarter valued at about $44,000. Hedge funds and other institutional investors own 89.24% of the company’s stock.

Wall Street Analysts Forecast Growth

ELV has been the subject of several recent analyst reports. Bank of America lifted their price target on Elevance Health from $435.00 to $460.00 and gave the company a “buy” rating in a report on Thursday. JPMorgan Chase & Co. lifted their price target on Elevance Health from $397.00 to $411.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. Weiss Ratings upgraded Elevance Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, May 18th. Wall Street Zen cut Elevance Health from a “buy” rating to a “hold” rating in a report on Sunday, February 8th. Finally, Truist Financial lifted their price target on Elevance Health from $375.00 to $450.00 and gave the company a “buy” rating in a report on Monday, June 1st. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $411.11.

Elevance Health Stock Performance

Elevance Health stock opened at $415.88 on Monday. The stock’s 50 day moving average price is $354.74 and its 200 day moving average price is $341.84. The firm has a market capitalization of $90.31 billion, a PE ratio of 17.69, a price-to-earnings-growth ratio of 2.35 and a beta of 0.67. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.48 and a current ratio of 1.48. Elevance Health, Inc. has a one year low of $273.71 and a one year high of $416.56.

Elevance Health (NYSE:ELV) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $12.58 EPS for the quarter, topping the consensus estimate of $10.74 by $1.84. The firm had revenue of $49.49 billion for the quarter, compared to analyst estimates of $48.21 billion. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.Elevance Health’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same period in the previous year, the company posted $11.97 EPS. Elevance Health has set its FY 2026 guidance at 19.850- EPS. As a group, sell-side analysts expect that Elevance Health, Inc. will post 26.94 EPS for the current fiscal year.

Elevance Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Wednesday, June 10th will be given a $1.72 dividend. This represents a $6.88 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Wednesday, June 10th. Elevance Health’s dividend payout ratio is presently 29.26%.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.